Etiometry IDO2 Index Cleared for Adult Oxygen Monitoring

The FDA has granted Etiometry clearance for adult use of its IDO2 Index, an algorithm which analyzes patient data from multiple devices and laboratory systems and alerts hospital staff when patients are suffering from inadequate oxygen.

The Etiometry platform displays the data on a single screen, reducing the need for manual tasks in critical care settings and situations, the company said.

IDO2 Index was first given FDA clearance in 2016 for neonatal patients and then gained expanded clearance in 2017 for patients 12 years and younger.

The index previously gained a CE mark and approval in Canada.